Shaw J P, Ratcliffe F
Arch Int Pharmacodyn Ther. 1976 Jul;222(1):116-24.
Administration of lithium carbonate (2 mEq/kg) i.p., twice daily for 3 days to mice did not significantly after brain 5-hydroxytryptamine (5-HT) levels; however, brain 5-hydroxyindoleacetic acid (5-H1AA) accumulation after i.p. injection of probenecid (200 mg/kg) was significantly increased in lithium pretreated animals. Brain 5-hydroxytryptophan decarboxylase activity was enhanced by lithium pretreatment while brain monoamine oxidase (MAO) activity was unaltered. After i.p. injection of the monoamine oxidase inhibitor pargyline (100 mg/kg) the accumulation of brain 5-HT was greater in lithium treated than control mice, while the decrease in brain 5-HT levels after i.p. treatment with the 5-HT synthesis inhibitor para-chlorophenylalanine (PCPA 300 mg/kg) was significantly less in lithium pretreated mice.
给小鼠腹腔注射碳酸锂(2 毫当量/千克),每日两次,持续3天,对脑内5-羟色胺(5-HT)水平无显著影响;然而,在预先用锂处理的动物中,腹腔注射丙磺舒(200毫克/千克)后,脑内5-羟吲哚乙酸(5-HIAA)的蓄积显著增加。锂预处理可增强脑内5-羟色氨酸脱羧酶的活性,而脑内单胺氧化酶(MAO)的活性未改变。腹腔注射单胺氧化酶抑制剂帕吉林(100毫克/千克)后,锂处理的小鼠脑内5-HT的蓄积量比对照小鼠更多,而在用5-HT合成抑制剂对氯苯丙氨酸(PCPA 300毫克/千克)进行腹腔处理后,预先用锂处理的小鼠脑内5-HT水平的降低明显较少。